Oncology & Cancer Predisposition Market Analysis

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

BRCA1/2, Lynch syndrome, and polygenic cancer risk panels represent the highest-value DTC segment, with consumers and clinicians both willing to pay premium prices for actionable results. FDA cleared several hereditary cancer tests under the 510(k) pathway, providing a regulatory template that sustains consumer trust.